Exact Mass: 1089.6613035999999
Exact Mass Matches: 1089.6613035999999
Found 18 metabolites which its exact mass value is equals to given mass value 1089.6613035999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
CDP-DG(18:2(9Z,11Z)/i-24:0)
CDP-DG(18:2(9Z,11Z)/i-24:0) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(18:2(9Z,11Z)/i-24:0), in particular, consists of one chain of (9Z,11Z)-octadecadienoic acid at the C-1 position and one chain of isotetracosanoic acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05\\% or so of the total phospholipids).
CDP-DG(i-24:0/18:2(9Z,11Z))
CDP-DG(i-24:0/18:2(9Z,11Z)) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(i-24:0/18:2(9Z,11Z)), in particular, consists of one chain of isotetracosanoic acid at the C-1 position and one chain of (9Z,11Z)-octadecadienoic acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05\\% or so of the total phospholipids).
(-)-sanglifehrin A|Sanglifehrin A|SFA
C60H91N5O13 (1089.6613035999999)
(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradeca-4,8,12-trien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide
(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide
3-{[15-(10-carbamimidamidodecan-2-yl)-5,7,9,11,23,25,27,31,33,34,35-undecahydroxy-10,14,18,22,26,30-hexamethyl-17-oxo-16,37-dioxabicyclo[31.3.1]heptatriaconta-12,18-dien-3-yl]oxy}-3-oxopropanoic acid
2',2'-n,n-dichloromethyltetrandrine
{"Ingredient_id": "HBIN003742","Ingredient_name": "2',2'-n,n-dichloromethyltetrandrine","Alias": "NA","Ingredient_formula": "Cl2N2O62+","Ingredient_Smile": "C[N+]1(CCC2=C3C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(C(=C(C=C7CC[N+]6(C)CCl)OC)OC)OC3=C(C=C2)OC)OC)CCl.[Cl-].[Cl-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15029","TCMID_id": "5418","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3s,6s,9r,10r,11s,12s,13e,15e,18s)-18-[(2e,4e,8s,9s)-10-[(2s,3r,4s,5s,6r,9s,11s)-9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl]-9-hydroxy-8-methyldeca-2,4-dien-2-yl]-5,8,10,12-tetrahydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-11-methyl-9-(3-oxobutyl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-4,7,13,15-tetraene-2,20-dione
C60H91N5O13 (1089.6613035999999)
(8e,10e,12e,25e)-5,16,21,32,33,36-hexabromo-12,25-bis(hydroxyimino)-2,18-dioxa-10,27-diazapentacyclo[28.2.2.2¹⁴,¹⁷.1³,⁷.1¹⁹,²³]octatriaconta-1(32),3(38),4,6,8,10,14,16,19(35),20,22,26,30,33,36-pentadecaene-4,11,20,26-tetrol
5,16,21,32,33,36-hexabromo-4,20-dihydroxy-12,25-bis(hydroxyimino)-2,18-dioxa-10,27-diazapentacyclo[28.2.2.2¹⁴,¹⁷.1³,⁷.1¹⁹,²³]octatriaconta-1(32),3(38),4,6,8,14,16,19(35),20,22,30,33,36-tridecaene-11,26-dione
(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-[(2e,4e,8s,9s)-10-[(2s,3r,4s,5s,6r,9s,11s)-9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl]-9-hydroxy-8-methyldeca-2,4-dien-2-yl]-5,8,10,12-tetrahydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-11-methyl-9-(3-oxobutyl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-4,7,13,15-tetraene-2,20-dione
C60H91N5O13 (1089.6613035999999)
18-(10-{9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl}-9-hydroxy-8-methyldeca-2,4-dien-2-yl)-5,8,10,12-tetrahydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-11-methyl-9-(3-oxobutyl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-4,7,13,15-tetraene-2,20-dione
C60H91N5O13 (1089.6613035999999)